MedTrace Logo

Safety and Usability of the STELO Exoskeleton in People With Acquired Brain Injury and Spinal Cord Injury

NCT05265377 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-05-22

No results posted yet for this study

Summary

Gait impairment in people with acquired brain injury (ABI) and spinal cord injury (SCI) can be very heterogeneous. For this reason, STELO has been developed: a new concept of exoskeleton based on modular technology for gait assistance. It allows a personalised configuration according to the functional capacity of each patient, as the therapist can choose which robotic joints to use depending on the therapeutic goal and on the patient recovery phase. The objective is to analyse the usability of the STELO modular exoskeleton in people with ABI and SCI.

Conditions

  • Spinal Cord Injury
  • Acquired Brain Injury

Interventions

DEVICE

Stelo

Use of Stelo exoskeleton in nine rehabilitation sessions

Sponsors & Collaborators

  • Centro de Referencia Estatal de Atención Al Daño Cerebral

    collaborator OTHER

  • National Research Council, Spain

    collaborator OTHER_GOV

  • Centro Lescer

    collaborator UNKNOWN

  • MarsiBionics

    lead INDUSTRY

Principal Investigators

  • Elena García Armada, Dr. · National Research Council

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-21
Primary Completion
2023-03-31
Completion
2023-04-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05265377 on ClinicalTrials.gov